MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Tabolacci, E. (Creator), Mancano, G. (Creator), Lanni, S. (Creator), Palumbo, F. (Creator), Goracci, M. (Creator), Ferrè, F. (Contributor), Helmer-Citterich, M. (Creator), Neri, G. (Creator) (2016). MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells. figshare. 10.6084/m9.figshare.c.3641399_d1